MedTrace Logo

Short-course Antimicrobial Therapy in Sepsis

NCT02899143 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2021-09-08

No results posted yet for this study

Summary

The purpose of this study is to compare the effect of a short course antimicrobial therapy (5-days) versus a 10-days therapy on sepsis-related organ dysfunction.

Conditions

Interventions

DRUG

Antibiotic

Targeted antimicrobial therapy

Sponsors & Collaborators

  • Ospedale Santa Maria delle Croci

    lead OTHER

Principal Investigators

  • Vincenzo De Santis · Ospedale Santa Maria Delle Croci, Ravenna, AUSL Romagna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02899143 on ClinicalTrials.gov